Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
cPMP in Molybdenum Cofactor Deficiency Type A
NCT00957749Phase 2Withdrawn
- Start
- Aug 2009
- Primary completion
- Apr 2010
- Modality
- Recombinant Proteins and Enzymes, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of fosdenopterin in molybdenum cofactor deficiency type A (MoCD-A). Planned start Aug 2009; status: withdrawn.
02
Drugs
fosdenopterin
03
Conditions
molybdenum cofactor deficiency type A (MoCD-A)
Beyond the preview
Go deeper on NCT00957749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00957749.